In this interview from AAO 2015, John Clough, CEO of Lenstec, discusses the development of segmented bifocal IOLs. He says the technology used to make the IOL prevents vision quality issues associated with transition zones typically seen with concentric multifocals. The IOL is under clinical investigation in the United States, it is in use internationally, demonstrating excellent visual outcomes with high patient satisfaction.